In this study, we analyze differences in the expression of various biomarkers, including STAT1, ADAR, CCL2, CXCL10, and miR-146a, in SLE patients treated with PDN, MMF, and HCQ versus untreated and healthy donors. Here, STAT1 is linked to systemic lupus erythematosus.